|
| |
QuintilesQuintiles Transnational Corp. is a market leader in providing full-service contract research, sales, marketing and healthcare policy consulting and health information management services to the global pharmaceutical, biotechnology, medical device and healthcare industries. Supported by its extensive information technology capabilities, the Company provides a broad range of contract services to help its clients reduce the length of time from the beginning of development to peak sales of a new drug or medical device. The Company's product development services include a full range of services focused on helping its clients through the development and regulatory approval of a new drug or medical device. The Company's commercialization services, including sales and specialized marketing support services, focus on helping its clients achieve commercial success for a new product or medical device. The Company also offers healthcare policy research and management consulting, which emphasize improving the quality, availability and cost-effectiveness of healthcare. Through its March 1999 acquisitions of Pharmaceutical Marketing Services, Inc. and ENVOY Corporation, the Company will also offer healthcare electronic data interchange, data mining and market research services which will form the core of its healthcare informatics services.
| Contact Details: |
| 4709 CREEKSTONE DRIVE, SUITE 200 |
| Durham |
| NC |
| 27703-8411 |
| United States of America |
| Tel: | 919 998 2000 |
| Fax: | |
| Email: | |
| WWW: | www.quintiles.com/
|
|
Loading...
|
Recent Publications by Quintiles: |  |
Personalized Medicine Enters the US Marketplace: KRAS, Anti-EGFR Monoclonal Antibodies, and Colon Cancer.
A rationale for the use of probiotics for a number of functional... | 16th October, 2009
| Department of Hematology, Oncology and Transplantation, Quintiles, Inc,
| Am J Ther. 2009 Oct 13.
DOI Direct Link |
Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development.
Following reports of death from cardiac arrhythmias with drugs like... | 25th September, 2009
| Quintiles ECG Services, Mumbai, India.
| Br J Pharmacol. 2009 Sep 23.
DOI Direct Link |
Epigenetic modifiers exacerbate oxidative stress in renal proximal tubule cells.
BACKGROUND: Increased production of reactive oxygen species (ROS) by... | 25th September, 2009
| Quintiles Hungary Ltd, Budapest, Hungary.
| Anticancer Res. 2009 Jun;29(6):2295-9.
|
Inter-individual variability of plasma PAF-acetylhydrolase activity in ARDS patients and PAFAH genotype.
BACKGROUND: Platelet activating factor (PAF), a pro-inflammatory... | 23rd September, 2009
| Clinical Pharmacology, Quintiles, Inc., Overland Park, KS, USA.
| J Clin Pharm Ther. 2009 Aug;34(4):447-55.
DOI Direct Link |
Treatment of depression: an update on antidepressant monotherapy and combination therapy.
We analyzed the trends in product regimens used to treat depression to... | 19th September, 2009
| Ms. Lenderts is Manager, Strategic Analytics, Quintiles, Inc.,/Innovex,
| Psychiatry (Edgmont). 2009 Aug;6(8):15-7.
|
→View more Quintiles research publications. |
Press Releases on Quintiles:
|
 |
| Global Phase III Study Results Show Eribulin Meets Primary Endpoint Of Overall Survival |
30th October, 2009 |
|
LONDON, October 30 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito)
today announced preliminary results from a recently completed Phase III study
with E7389
|
| Soligenix Appoints Robert J. Rubin, MD, to its Board of Directors |
9th October, 2009 |
Soligenix, Inc. |
PRINCETON, N.J., Oct. 9 /PRNewswire-FirstCall/ -- Soligenix, Inc. (Soligenix or the Company), (OTC Bulletin Board: SNGX), a late-stage biopharmaceutical company, announced today that Robert J. Rubin,
|
| InterMune Reports Second Quarter 2009 Financial Results and Business Highlights |
6th August, 2009 |
InterMune, Inc. |
-- New, pre-specified exploratory efficacy data from CAPACITY
pertaining to dose-effect relationships, mean change in FVC volume
and Six-Minute Walk Test distance that
|
| Campbell Alliance Adds Industry Veterans Jon W. McGarity and David Lilley as Executive Vice Presidents |
17th June, 2009 |
Campbell Alliance |
RALEIGH, N.C., June 17 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that it has appointed industry
|
| HITSP Begins Harmonization Process for Use of Electronic Health Records in Clinical Research |
15th June, 2009 |
American National Standards Institute |
Thirty-five leading organizations from the clinical research community have pledged support for new initiative
WASHINGTON, June 15 /PRNewswire-USNewswire/ -- The Healthcare Information Technology
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 36 individuals from Quintiles using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 639 times since April 2007, the link to the organisation's website has been followed 77 times Recent Search Terms used to find this page: quintiles database informatics | AZ and Quintiles alliance and press release | quintiles and astrazeneca | quintiles and 2009 financial results | quintiles and astrazeneca deal | astrazeneca quintiles outsourcing | astrazeneca quintiles | astrazeneca quintiles | quintiles august 2009 | TSQM-9 german version | . Search for more companies in Durham Search for more companies in NC This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Quintiles |
